126 related articles for article (PubMed ID: 34555684)
1. PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis.
Zhang F; Jiang N; Gao Y; Fan Z; Li Q; Ke G; Li B; Wu Q; Xu R; Liu S
Biochem Biophys Res Commun; 2021 Nov; 577():165-172. PubMed ID: 34555684
[TBL] [Abstract][Full Text] [Related]
2. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis reveals long non‑coding RNA SOX2OT as a novel candidate regulator in diabetic nephropathy.
Zhang X; Shang J; Wang X; Cheng G; Jiang Y; Liu D; Xiao J; Zhao Z
Mol Med Rep; 2018 Dec; 18(6):5058-5068. PubMed ID: 30320339
[TBL] [Abstract][Full Text] [Related]
4. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
Nie H; Yang H; Cheng L; Yu J
J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
[No Abstract] [Full Text] [Related]
5. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
6. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
7. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
[TBL] [Abstract][Full Text] [Related]
8. Nine hub genes as the potential indicator for the clinical outcome of diabetic nephropathy.
Song X; Gong M; Chen Y; Liu H; Zhang J
J Cell Physiol; 2019 Feb; 234(2):1461-1468. PubMed ID: 30078220
[TBL] [Abstract][Full Text] [Related]
9. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
10. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
Gui H; Chen X; Ye L; Ma H
Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.
Cai H; Zeng Y; Luo D; Shao Y; Liu M; Wu J; Gao X; Zheng J; Zhou L; Liu F
Genomics; 2024 Jul; 116(4):110879. PubMed ID: 38851464
[TBL] [Abstract][Full Text] [Related]
12. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis.
Han Y; Jin L; Wang L; Wei L; Tu C
Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224
[TBL] [Abstract][Full Text] [Related]
13. Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway.
Dai ZW; Cai KD; Xu LC; Wang LL
Mol Cell Probes; 2020 Oct; 53():101584. PubMed ID: 32387304
[TBL] [Abstract][Full Text] [Related]
14. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
16. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y
J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
18. Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy.
Li Y; Lin H; Shu S; Sun Y; Lai W; Chen W; Hu Z; Peng H
FASEB J; 2022 Nov; 36(11):e22592. PubMed ID: 36251411
[TBL] [Abstract][Full Text] [Related]
19. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
20. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
Wang Y; Feng F; He W; Sun L; He Q; Jin J
Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
